Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.33 |
| ▸ | SPIN1 | Q9Y657 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16673949 | 0.75 | CYP3A4 (0.44) | EHMT2ACHE | |
| SCHEMBL25565740 | 0.74 | EHMT2 (0.32) | EHMT2SPIN1ACHE | |
| SCHEMBL23071760 | 0.68 | ALDH1A1 (0.38) | TLR8ACHECSNK2A1 | |
| SCHEMBL12729988 | 0.65 | CA1 (0.36) | ACHE | |
| SCHEMBL11544312 | 0.64 | TLR8 (0.42) | TLR8ACHECSNK2A1 | |
| SCHEMBL28844605 | 0.64 | MAPT (0.43) | TLR8CSNK2A1 | |
| SCHEMBL30131979 | 0.64 | ALDH1A1 (0.36) | — | |
| SCHEMBL21440629 | 0.64 | PTK2 (0.44) | — | |
| SCHEMBL9988792 | 0.64 | ALDH1A1 (0.36) | — | |
| SCHEMBL4460699 | 0.64 | KCNH2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | EHMT2 3340/4885SPIN1 4490/4885TLR8 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.